SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-115299
Filing Date
2016-04-28
Accepted
2016-04-28 16:11:44
Documents
4
Period of Report
2016-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-9600_18k.htm 8-K 66116
2 EX-99.1 a16-9600_1ex99d1.htm EX-99.1 241180
3 EX-99.2 a16-9600_1ex99d2.htm EX-99.2 74869
4 GRAPHIC g96001mmi001.jpg GRAPHIC 3064
  Complete submission text file 0001104659-16-115299.txt   388143
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 161600198
SIC: 2834 Pharmaceutical Preparations